|
|
Correlations between plasma NT-ProBNP, hs-CRP and serum IL-10 levels and heart function in elderly patients with chronic heart failure |
WEN Fangmei1, SHAN Zimei2, and GAO Shuang3 |
1.Department of The First Gerontotherapeutics, 2.Cadre Ward Care Center,Xinjiang Municipal People’s Hospital,Urumqi 830001,China. 3. Xinjiang Municipal Corps Hospital of Chinese People’s Armed police Force, Urumqi 830091,China |
|
|
Abstract Objective To study the clinical correlations between plasma NT-ProBNP, hs-CRP and serum IL-10 levels and the heart function in elderly patients with chronic heart failure.Methods 79 elderly patients with chronic heart failure treated in this hospital from November 2014 to December 2015 were recruited as study group,another 45 healthy volunteers as control group.The cardiac function,IL-10,hs-CRP and NT-ProBNP indexes of patients in the two groups were detected by Doppler ultrasonography,enzyme linked immunosorbent assay,immunoassay and colloidal gold Methods.Results In the study group,35 patrents had normal cardiac systolic function, and the other 44 patients had systolic dysfunction.The NT-ProBNP, hs-CRP levels in the normal cardiac systolic function group and systolic dysfunction group were significantly higher than those in the control group,while the IL-10 level was significantly lower;the difference was statistically significant between the 3 groups(P<0.05).The NT-ProBNP and hs-CRP levels of different cardiac function classification in the study group were significantly higher than those in the control group,while the IL-10 level was significantly lower;the difference was statistically significant between the 4 groups(P<0.05). The NT-ProBNP and hs-CRP levels were positively correlated with the cardiac functional grading(P<0.05), while there was a negative correlation between the IL-10 level and the cardiac functional grading(P<0.05).Conclusions The levels of plasma NT-ProBNP, hs-CRP and serum IL-10 are obviously correlated with cardiac function in elderly patients with chronic heart failure,which can be used as an important indicator for clinical diagnosis and disease evaluation.
|
Received: 21 April 2016
|
|
|
|
|
[1] |
王 琛,唐 彤.心力衰竭研究的进展与展望[J].中华高血压杂志,2012,20(12):1102-1105.
|
[2] |
王 翔,易省阳.慢性心力衰竭诊断及治疗新进展[J].中华实用诊断与治疗杂志,2015,29(1):10-12.
|
[3] |
吴学思.2005年欧美慢性心力衰竭诊疗指南简介[J].心肺血管病杂志,2006,24(3):182-185.
|
[4] |
甄宇治,邓彦东,刘坤申.慢性心力衰竭伴利尿剂抵抗的研究进展[J].中国全科医学,2012,15(11):1290-1292.
|
[5] |
周云艳,孔一慧,李为民.心力衰竭与炎性细胞因子相关研究新进展[J].心血管病学进展,2014,35(5):543-546.
|
[6] |
宗雪梅,孙鸿彬,宋芙荣,等.多种生化指标联合检测在心力衰竭诊断及预后评估中的意义[J]. 中华实用诊断与治疗杂志,2014,28(1):73-74.
|
[7] |
Coles A H,Tisminetzky M, Yarzebski J, et al. Magnitude of and Prognostic Factors Associated With 1-Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction Findings[J]. J Am Heart Assoc,2015,4(12):576-572.
|
[8] |
廖玉华,程 翔,袁 璟,等.心力衰竭的免疫发病机制与治疗策略[J].临床心血管病杂志,2013,29(6):401-403.
|
[9] |
Kobalava Z D,Pavlikova E P,Averkov O A,et al. First Experience of Clinical Application of LCZ696-an AT1-angiotensin Receptors and Neprilysin Inhibitor-in Patients With Chronic Heart Failure and Reduced Ejection Fraction[J]. Kardiologiia, 2015,55(7):14-25.
|
[10] |
王 焱,覃 珊,张自强.心力衰竭高敏C反应蛋白和脑钠肽变化及其与心功能的关系[J]. 医学综述,2015,21(19):3625-3627 .
|
[11] |
Hahn R G,Jaarsma T,Waldréus N,et al.Urine measurement indicates the plasma brain natriuretic peptide concentration during optimization of heart failure treatment[J] .Scand J Clin Lab Invest, 2015,17(17):1-6.
|
[12] |
周清芬,张凤如,璩 斌.慢性心力衰竭危险因素对炎症因子的影响作用[J]. 内科理论与实践,2015,10(2):116-118.
|
[13] |
段佳佳,夏大胜.慢性心力衰竭患者炎性细胞因子的变化及作用[J]. 中国心血管杂志,2012,17(2):93-95.
|
[14] |
刘 茂,陈 剑,黄 丹,等.慢性心力衰竭患者血清促炎细胞因子水平变化的系统评价[J]. 中国全科医学,2014,17(28):3363-3367.
|
[15] |
王梦龙,万 军,刘剑芳,等. IL-10在心力衰竭患者心肌中的表达及其与心肌氧化应激关系的研究[J]. 医学研究杂志,2014,43(10):103-106.
|
|
|
|